Emerald Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,615
Closed -$337K 227
2022
Q4
$337K Sell
3,615
-5,770
-61% -$557K 0.02% 184
2022
Q3
$895K Buy
9,385
+3
+0% +$297 0.05% 141
2022
Q2
$869K Buy
9,382
+3,769
+67% +$368K 0.04% 148
2022
Q1
$568K Buy
5,613
+1,253
+29% +$132K 0.02% 184
2021
Q4
$450K Buy
+4,360
New +$403K 0.02% 193
2021
Q3
Sell
-584
Closed -$49K 257
2021
Q2
$49K Buy
+584
New +$47.8K ﹤0.01% 259
2021
Q1
Sell
-576
Closed -$39K 263
2020
Q4
$39K Buy
576
+5
+0.9% +$325 ﹤0.01% 269
2020
Q3
$33K Buy
571
+4
+0.7% +$249 ﹤0.01% 266
2020
Q2
$37K Buy
+567
New +$35.7K ﹤0.01% 252
2020
Q1
Sell
-558
Closed -$41K 238
2019
Q4
$41K Buy
+558
New +$39.2K ﹤0.01% 284
2015
Q2
Sell
-3,782
Closed -$386K 332
2015
Q1
$386K Buy
3,782
+21
+0.6% +$2.13K 0.02% 291
2014
Q4
$362K Sell
3,761
-580
-13% -$51.1K 0.02% 287
2014
Q3
$345K Sell
4,341
-1,664
-28% -$131K 0.02% 294
2014
Q2
$453K Sell
6,005
-262
-4% -$19.8K 0.03% 287
2014
Q1
$469K Sell
6,267
-890
-12% -$62.9K 0.03% 289
2013
Q4
$512K Buy
7,157
+750
+12% +$48.2K 0.03% 276
2013
Q3
$364K Sell
6,407
-45
-0.7% -$2.68K 0.02% 298
2013
Q2
$369K Buy
+6,452
New +$374K 0.02% 289

Other funds holding CVS

Emerald Advisers's CVS Position: Q1 2023 in Review

Emerald Advisers sold out of CVS Health (CVS) in Q1 2023, closing a stake of 3,615 shares — an estimated $337K sold.

Emerald Advisers first reported a position in CVS in Q2 2013 and held it in 18 quarters. The position peaked at $895K in Q3 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Emerald Advisers reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Emerald Advisers sold 3,615 CVS Health shares in Q1 2023, an estimated $337K.
  • Emerald Advisers first reported a position in CVS Health in Q2 2013 and held it in 18 quarters.
  • Emerald Advisers's CVS Health position peaked at $895K in Q3 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.